Insights on Clinical Trials
-
Oncology Clinical Trials Case Study: I-SPY 2 & OpenClinica
4/17/2025
The I-SPY 2 trial represents a pioneering effort in the field of oncology, specifically targeting the development of personalized treatments for breast cancer.
-
Consent By Proxy: The Key To More Inclusive, More Reliable Trials
4/17/2025
Explore innovative digital workflow designed specifically for Legally Authorized Representative (LAR) to help overcome the challenges of complex documentation and data management issues.
-
EHR-To-EDC Success In A Complex, Adaptive Platform Trial
4/17/2025
I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.
-
Unlocking Recruitment Potential In Trial-Naïve Sites
4/17/2025
Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.
-
Delivering Specialist Neurology Support
4/17/2025
Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.
-
Enhance Access And Improve Retention In Rare Disease Trials With HTS
4/17/2025
Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.
-
High Density, Low Availability: Rethinking Ophthalmic Trial Readiness
4/16/2025
The adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
-
Accelerate Your Oncology Breakthroughs
4/16/2025
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
-
A High-Touch, Patient-Centered Approach For Advancing Rare Disease Trials
4/15/2025
On your journey to developing and executing a successful rare disease trial, it is critical to focus on patient experience and accessibility from the earliest stages of trial design.
-
The Rescue Option: Course Correcting Struggling Clinical Trials
4/14/2025
The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.